Internal Medicine · Lebanon, MO
NPI
1912078452
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
120 Hospital Dr, Suite 300
Lebanon, MO, 65536
Phone (417) 533-6746
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
5,764 services
Medicare patients, 2024
411
Average age 74
Drug cost, 2024
$2.2M
20,521 prescriptions
Company payments, 2025
$793
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ossama Al-Assafeen was code 99214 (office e&m - established), 1,351 times for 390 patients. In total Ossama Al-Assafeen billed 5,764 services in 74 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,351 | 390 | $83.86 | $113K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,290 | 11 | $0.10 | $125 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 911 | 78 | $0.69 | $628 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 361 | 31 | $0.08 | $30.25 |
| 96372 Injection Administration | Office | 284 | 73 | $10.19 | $2,894 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 197 | 144 | $11.48 | $2,262 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 158 | 15 | $0.95 | $149 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 155 | 33 | $0.34 | $52.95 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 154 | 154 | $125.88 | $19K |
| 20610 Joint Injection | Office | 125 | 70 | $47.24 | $5,906 |
| 99213 Office E&M - Established | Office | 103 | 83 | $64.28 | $6,621 |
| 81003 Clinical Chemistry | Office | 78 | 43 | $2.20 | $172 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 76 | 17 | $0.47 | $35.64 |
| G0008 Administration of influenza virus vaccine | Office | 42 | 42 | $29.84 | $1,253 |
| 90653 Vaccine Product | Office | 39 | 39 | $79.72 | $3,109 |
By year: 2022 $163K for 3,434 services; 2023 $166K for 3,843 services; 2024 $168K for 5,764 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 78 | 43 | $2.20 | $172 |
Medicare prescription drug claims, 2024
In 2024, the drug Ossama Al-Assafeen prescribed most often to Medicare patients was Atorvastatin Calcium, with 846 prescriptions and refills. In total Ossama Al-Assafeen wrote 20,521 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 846 | 2,199 | 231 | $6,787 |
| Levothyroxine Sodium Generic | 815 | 2,168 | 217 | $7,427 |
| Pantoprazole Sodium Generic | 642 | 1,528 | 172 | $7,996 |
| Rosuvastatin Calcium Generic | 457 | 1,270 | 130 | $5,888 |
| Metoprolol Succinate Generic | 456 | 1,048 | 111 | $5,708 |
| Gabapentin Generic | 432 | 818 | 108 | $9,438 |
| Lisinopril Generic | 405 | 1,018 | 107 | $2,776 |
| Trazodone Hcl Generic | 354 | 702 | 95 | $3,142 |
| Amlodipine Besylate Generic | 334 | 884 | 92 | $1,958 |
| Glimepiride Generic | 312 | 778 | 83 | $2,367 |
| Mounjaro Tirzepatide | 302 | 370 | 56 | $382K |
| Omeprazole Generic | 295 | 737 | 83 | $5,424 |
| Losartan Potassium Generic | 284 | 768 | 77 | $2,778 |
| Prednisone Generic | 273 | 315 | 163 | $579 |
| Tamsulosin Hcl Generic | 258 | 638 | 67 | $4,347 |
Brand drugs: 2,700 claims; generic drugs: 17,711 claims; opioid claims: 517.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ossama Al-Assafeen $793 ($793 in general payments such as food, travel and fees) from 14 companies. The largest payer was Pfizer Inc. with $155.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 17 | $155 |
| Abbvie Inc. ABBV | 4 | $90.09 |
| Abbott Laboratories ABT | 4 | $88.4 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $76.1 |
| Ardelyx, Inc. ARDX | 3 | $71.29 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $60.98 |
| Saluda Medical Americas, Inc. | 3 | $60 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $47.29 |
| Lilly USA, LLC LLY | 2 | $32.99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $30.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.